Panitumumab: prices and alternatives
Panitumumab is an EGFR antagonist indicated for adult patients with wild-type RAS metastatic colorectal cancer (mCRC), either in combination with FOLFOX as first-line therapy or as monotherapy after prior fluoropyrimidine, oxaliplatin, and irinotecan-based chemotherapy. Also used with sotorasib for KRAS G12C-mutated…
2 products with this active ingredient from 1 manufacturer. Official prices from 6624 to 26046 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.